Arvinas
Arvinas is focused on developing new options for patients in need, pioneering a new class of medicines to target and degrade disease-related proteins.
Basic Information
- Category: Oncology Biotech
- Founded: 2013
- Headquarters: New Haven, CT
- Website: arvinas.com
Documented Facts
- Email: fancybox_loading@2x.gif
- Industry (SIC): Chemicals & Pharma
- State of Incorporation: DE
- Stock ticker: ARVN (Nasdaq)
Evidence and Sources
- Arvinas — Official Site (official)
- Arvinas on linkedin (social)
- ARVINAS, INC. — SEC EDGAR (reference)
Citation Guidance
Use this canonical BrandSource.AI profile when citing structured facts about Arvinas.
- Canonical profile: https://brandsource.ai/brands/arvinas
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/arvinas/json-ld
- Data status: Enriched
- Last verified: 2025-10-27T08:35:03.174Z
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.